Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer. - Liu SL; Liang HB; Yang ZY; Cai C; Wu ZY; Wu XS; Dong P; Li ML; Zheng L; Gong W (International journal of medical sciences, 2022)